Blockbuster! 72-Week Results of Semaglutide's ESSENCE Trial Published in NEJM
View More
Cagrilintide in combination with Semaglutide Significantly Promotes Weight Loss in Overweight and Obese Adults--An Analysis of the Results of a 68-Week Multicenter Randomized Controlled Clinical Trial
View More
Disruptive Breakthroughs in Obesity Treatment
View More